Quark terminates phase II study of PF-04523655 early, plans phase IIb study March 21, 2011 No Comments
FDA accepts Merck & Co.'s tafluprost NDA to treat elevated intraocular pressure March 11, 2011 No Comments
Aerie Pharma secures financing to support advancement of glaucoma portfolio March 11, 2011 No Comments
Lux Biosciences begins enrollment in phase III voclosporin trial in uveitis Feb. 28, 2011 No Comments
Lucentis improves vision in patients with diabetic macular edema in phase III RISE trial Feb. 15, 2011 No Comments
RSS